NEW YORK (GenomeWeb News) – Caprotec Bioanalytics announced today that it has received a total of €6 million ($8.8 million) from two rounds of private financing to support further development and marketing of the firm’s Capture Compound Mass Spectrometry technology for analyzing complex protein mixtures.
 
Investors in the two rounds included Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and private investors including Heinrich-Maria Schulte, co-founder of Evotec and owner of the Wölbern Bank in Hamburg, Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.